sesamin has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, L; Li, S; Liu, Q; Qiao, Y; Sui, Y; Zhao, Y | 1 |
| Kongtawelert, P; Phitak, T; Pothacharoen, P; Shwe, TH; Wudtiwai, B | 1 |
2 other study(ies) available for sesamin and Adenocarcinoma
| Article | Year |
|---|---|
Identification of a natural compound, sesamin, as a novel TRPM8 antagonist with inhibitory effects on prostate adenocarcinoma.
Topics: Adenocarcinoma; Cell Line, Tumor; Cell Proliferation; Dioxoles; HEK293 Cells; Humans; Lignans; Male; Molecular Docking Simulation; Molecular Structure; Prostatic Neoplasms; TRPM Cation Channels | 2020 |
Inhibition of programmed death ligand 1 (PD-L1) expression in breast cancer cells by sesamin.
Topics: Adenocarcinoma; B7-H1 Antigen; Biomarkers, Tumor; Breast Neoplasms; Cell Proliferation; Dioxoles; Female; Humans; Janus Kinases; Lignans; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; MCF-7 Cells; NF-kappa B; Proto-Oncogene Proteins c-akt; Signal Transduction; STAT Transcription Factors; Triple Negative Breast Neoplasms; Up-Regulation | 2020 |